Quick Answer
Alaunos Therapeutics, Inc. reported Total Revenue of $5.0 thousand for fiscal year 2025.
Alaunos Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $5.0K | -50.0% |
| 2024 | $10.0K | +100.0% |
| 2023 | $5.0K | -99.8% |
| 2022 | $2.92M | +634.2% |
| 2021 | $398.0K | — |
| 2020 | $0.00 | -100.0% |
| 2018 | $146.0K | -97.7% |
| 2017 | $6.39M | -6.9% |
| 2016 | $6.86M | +757.6% |
| 2012 | $800.0K | +19.9% |
| 2011 | $667.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | -100.0% | -100.0% |
| March 31, 2025 | $2.0K | +100.0% | — |
| September 30, 2024 | $0.00 | — | -100.0% |
| June 30, 2024 | $4.0K | +0.0% | +300.0% |
| March 31, 2024 | $1.0K | — | — |
| September 30, 2023 | $0.00 | -100.0% | -100.0% |
| June 30, 2023 | $4.0K | — | — |
- Alaunos Therapeutics, Inc. showed a decrease of -50.0% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, Alaunos Therapeutics, Inc.’s total revenue has declined by 99.3% (from $667.0 thousand to $5.0 thousand).
- The most recent figure is from Alaunos Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: